![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
https://tiefenbacher-pharmaceuticals.com/2024/05/02/tiefenbacher-group-renovation-of-headquarters-in-hamburg/
https://tiefenbacher-pharmaceuticals.com/2024/04/09/tiefenbacher-first-to-market-launch-rivaroxaban/
https://tiefenbacher-pharmaceuticals.com/2024/04/08/tiefenbacher-group-welcomes-new-coo-sandip-tarate/
https://tiefenbacher-pharmaceuticals.com/2024/03/19/tiefenbacher-group-awarded-ecovadis-silver-medal/
https://tiefenbacher-pharmaceuticals.com/2024/02/29/tiefenbacher-group-on-awareness-for-rare-disease-day/
https://tiefenbacher-pharmaceuticals.com/2024/02/14/tiefenbacher-group-renovation-of-headquarters/
https://tiefenbacher-pharmaceuticals.com/2023/09/27/launch-tiefenbacher-pharmaceuticals-generic-version-teriflunomide/
https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/
https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/